查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855962

2025年量子增强预测基因组学全球市场报告

Quantum-Enhanced Predictive Genomics Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，量子增强预测基因组学市场呈指数级增长，从2024年的14.5亿美元增长到2025年的19.5亿美元，复合年增长率达34.1%。这段历史性成长时期主要受以下因素驱动：精准医疗需求不断增长、基因组数据日益复杂、量子运算投资不断增加、疾病预测应用范围不断扩大以及科技与医疗保健产业合作日益密切。

预计未来几年，量子增强预测基因组学市场将呈指数级增长，到2029年市场规模将达到62.6亿美元，年复合成长率（CAGR）高达33.8%。预测期内的成长主要受以下因素驱动：个人化医疗的广泛应用、人工智慧与量子基因组学的日益融合、对疾病早期检测的日益重视、政府和私人研发投入的增加以及先进基因组数据集的广泛应用。这段时期的关键趋势包括：量子机器学习模型的开发、基因组资料加密和安全的创新、多体学与量子分析的融合、云端基础的量子基因组学平台的开发以及量子技术公司与生物技术公司之间的合作。

量子增强预测基因组学利用量子计算分析复杂的基因组数据，以便更快、更准确地预测疾病风险、治疗反应和其他健康结果。这种方法能够识别大型基因资料集中的模式，而这些模式往往被传统方法所忽略，从而支持生物标记的发现和个人化医疗。

量子增强预测基因体学的关键技术包括量子计算、量子机器学习、量子密码学及相关工具。量子运算是一种先进的运算平台，旨在快速分析和解读复杂的基因组数据。这些解决方案可部署在云端基础或本地环境中，并被製药和生物技术公司、研究机构、医疗保健提供者以及其他从事基因组学和精准医疗的组织广泛应用。

美国在2025年春季突然提高关税，由此引发的贸易摩擦对医疗保健产业造成了严重衝击，尤其对关键医疗设备、诊断试剂和药品的供应造成了严重影响。医院和医疗机构面临进口手术器械、影像设备以及注射器、导管等耗材成本不断上涨的困境。这些成本的增加加剧了医疗预算的紧张，导致一些医疗机构必须推迟设备升级或将成本转嫁给患者。此外，原料和零件的关税也阻碍了必需药品和医疗设备的生产，造成供应链瓶颈。为了应对这项挑战，医疗产业正在积极调整筹资策略，尽可能地促进本地生产，并呼吁对紧急医疗产品实施关税豁免。

本研究报告是商业研究公司（The Business Research Company）最新系列报告的一部分，提供量子增强预测基因组学市场统计数据，例如全球市场规模、区域份额、占据量子增强预测基因组学市场份额的竞争对手、详细的量子增强预测基因组学市场细分、市场趋势以及量子增强预测基因组学行业的商业机会。本量子增强预测基因组学市场研究报告提供您所需的一切信息，并对该行业的现状和未来发展趋势进行详细分析。

预计对个人化医疗日益增长的需求将推动量子增强型预测基因组学市场的成长。个人化医疗是指根据个人独特的基因、生物学和临床特征，量身订做医疗、治疗和预防策略。对个人化医疗需求的成长主要源自于其提高治疗效果的能力。针对患者基因组成所製定的治疗方法通常能带来更好的疗效和更少的副作用。量子增强型预测基因组学在其中发挥关键作用，它能够对复杂的基因组数据进行超快速分析，使临床医生能够制定高度精准的个人化治疗方案。例如，英国国家医疗服务体系（NHS）英格兰分部报告称，2024年透过NHS基因组医学服务为患者提供了超过81万次个人化基因组检测，比上一年增长了8%，这反映了对基因组主导医疗服务日益增长的需求。因此，对个人化医疗的需求预计将推动量子增强型预测基因组学市场的成长。

量子增强预测基因组学市场的主要企业正致力于高通量基因组数据处理等创新技术，以加速基因突变的识别，提高个人化医疗的预测准确性，并实现对复杂基因组数据集更快、更准确的分析。高通量基因组资料处理是指利用先进的计算方法对基因组序列进行快速、大规模的分析。例如，2025年6月，总部位于德国的Norma集团（专注于工程化和标准化偶联及流体处理技术的公司）与首尔大学盆唐医院（SNUBH）合作，将量子演算法应用于大规模基因组分析。此次合作旨在透过量子组合优化加速基因突变的检测，并提高基因组数据处理的速度和准确性，使其优于传统计算方法。其主要应用包括精准诊断、个人化治疗方案製定以及癌症和神经系统疾病的遗传风险评估。

2025年8月，英国软体公司Quantinuum将与惠康桑格研究所合作，推动量子运算在基因组学领域的应用。此次合作是桑格研究所「惠康生物量子飞跃」（Q4Bio）挑战计画的一部分，该计画是一项旨在支持基于量子技术的基因组分析研究的全球性倡议。惠康桑格研究所致力于开发量子增强型预测基因组学解决方案。

量子增强型预测基因组学市场由提供临床决策支援服务、肿瘤特异性预测基因组学服务和多组体学整合服务等服务的营业单位所获得的收入组成。市场价值包括服务供应商销售的或包含在其服务产品中的相关产品的价值。量子增强型预测基因组学市场包括量子驱动的表观遗传预测工具、量子整合的个人化预防医学工具和量子增强型合成生物学设计平台的销售。该市场的价值为“出厂价”，即产品製造商或创建者向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品创建者销售的任何相关服务的价值。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球量子增强预测基因体学：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球量子增强预测基因组学市场：成长率分析
  • 全球量子增强预测基因组学市场表现：规模与成长，2019-2024年
  • 全球量子增强基因组学市场预测：规模与成长，2024-2029年，2034年预测
  • 全球量子增强预测基因体学：潜在市场规模 (TAM)

第六章 市场细分

  • 全球量子增强基因体学市场：依技术、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 量子计算
  • 量子机器学习
  • 量子密码学
  • 其他技术
  • 全球量子增强基因体学市场依部署模式划分，实际数据及预测（2019-2024年、2024-2029年预测、2034年预测）。
  • 本地部署
  • 云端基础的
  • 全球量子增强基因体学市场：依应用领域划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 疾病风险评估
  • 药物发现
  • 个人化医疗
  • 基因组数据分析
  • 其他用途
  • 全球量子增强基因体学市场：依最终用户划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 製药和生物技术公司
  • 研究所
  • 医疗保健提供者
  • 其他最终用户
  • 全球量子增强基因体学市场：以量子计算、类型、实际值和预测值（2019-2024年、2024-2029年预测值、2034年预测值）进行细分
  • 基于闸的量子计算
  • 量子退火
  • 拓朴量子计算
  • 光子量子运算
  • 全球量子增强预测基因组学市场：按量子机器学习、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 监督式学习
  • 无监督学习
  • 强化学习
  • 深度学习
  • 全球量子增强基因组学市场：按量子密码学、类型、性能和预测进行细分，2019-2024年、2024-2029年预测、2034年预测
  • 量子金钥分发
  • 量子随机数生成
  • 量子安全通讯
  • 后量子密码学
  • 全球量子增强基因体学市场：依技术、类型、实际值及预测值细分，2019-2024年、2024-2029年预测值、2034年预测值
  • 量子感测器
  • 量子模拟
  • 量子网路
  • 混合量子-经典系统

第七章 区域和国家分析

  • 全球量子增强基因体学市场：依地区划分，实际值及预测值，2019-2024年、2024-2029年预测值、2034年预测值
  • 全球量子增强基因组学市场：按国家/地区划分，实际值和预测值，2019-2024 年、2024-2029 年预测值、2034 年预测值

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章：西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章：俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 量子增强预测基因体学市场：竞争格局
  • 量子增强预测基因组学市场：公司概况
    • Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
    • Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • F. Hoffmann-La Roche AG
  • Accenture plc
  • IBM Corporation
  • Pfizer Inc.
  • Bayer AG
  • AstraZeneca plc
  • GlaxoSmithKline plc
  • Honeywell International Inc.
  • Fujitsu Limited
  • Eviden
  • Xanadu Quantum Technologies Inc.
  • Pasqal SA
  • Rigetti Computing Inc.
  • IonQ Inc.
  • D-Wave Systems Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年量子增强预测基因体学市场：提供新机会的国家
  • 2029年量子增强预测基因体学市场：提供新机会的细分市场
  • 2029年量子增强预测基因体学市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38614

Quantum-enhanced predictive genomics involves using quantum computing to analyze complex genomic data, enabling faster and more precise predictions of disease risk, treatment response, and other health outcomes. This approach identifies patterns in large-scale genetic datasets that conventional methods may overlook, supporting biomarker discovery and personalized medicine.

The primary technologies in quantum-enhanced predictive genomics include quantum computing, quantum machine learning, quantum cryptography, and related tools. Quantum computing consists of advanced computational platforms designed for rapid analysis and interpretation of complex genomic datasets. These solutions can be deployed in cloud-based or on-premises environments and are used by pharmaceutical and biotechnology companies, research institutes, healthcare providers, and other organizations engaged in genomics and precision medicine.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The quantum-enhanced predictive genomics market research report is one of a series of new reports from The Business Research Company that provides quantum-enhanced predictive genomics market statistics, including the quantum-enhanced predictive genomics industry global market size, regional shares, competitors with the quantum-enhanced predictive genomics market share, detailed quantum-enhanced predictive genomics market segments, market trends, and opportunities, and any further data you may need to thrive in the quantum-enhanced predictive genomics industry. This quantum-enhanced predictive genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The quantum-enhanced predictive genomics market size has grown exponentially in recent years. It will grow from $1.45 billion in 2024 to $1.95 billion in 2025 at a compound annual growth rate (CAGR) of 34.1%. The growth during the historic period is driven by rising demand for precision medicine, increasing complexity of genomic data, growing investments in quantum computing, expanding applications in disease prediction, and stronger collaborations between technology and healthcare sectors.

The quantum-enhanced predictive genomics market size is expected to see exponential growth in the next few years. It will grow to $6.26 billion in 2029 at a compound annual growth rate (CAGR) of 33.8%. The projected growth in the forecast period is supported by wider adoption of personalized healthcare, greater integration of AI with quantum genomics, increased focus on early disease detection, rising government and private R&D funding, and broader availability of advanced genomic datasets. Key trends in this period include advancements in quantum machine learning models, innovations in genomic data encryption and security, integration of multi-omics with quantum analytics, development of cloud-based quantum genomics platforms, and collaborations between quantum technology firms and biotechnology companies.

The increasing demand for personalized medicine is anticipated to drive the growth of the quantum-enhanced predictive genomics market. Personalized medicine involves tailoring medical care, treatments, and prevention strategies based on an individual's unique genetic, biological, and clinical profile. The rise in demand for personalized medicine is largely due to its ability to improve treatment effectiveness. Therapies that are tailored to a patient's genetic makeup often lead to better outcomes and fewer side effects. Quantum-enhanced predictive genomics plays a key role in this by enabling ultra-fast analysis of complex genomic data, which allows clinicians to develop highly precise and individualized treatment plans. For example, in 2024, NHS England reported that over 810,000 personalized genomic tests were delivered to patients through the NHS genomic medicine service, an 8% increase from the previous year, reflecting the growing demand for genomic-led care. As a result, the demand for personalized medicine is expected to fuel the growth of the quantum-enhanced predictive genomics market.

Leading companies in the quantum-enhanced predictive genomics market are focusing on innovations such as high-throughput genomic data processing to speed up the identification of genetic variations, enhance predictive accuracy in personalized medicine, and enable faster, more precise analysis of complex genomic datasets. High-throughput genomic data processing refers to the rapid, large-scale analysis of genomic sequences using advanced computational methods. For instance, in June 2025, Norma Group, a Germany-based company specializing in engineered and standardized joining and fluid-handling technology, partnered with Seoul National University Bundang Hospital (SNUBH) to apply quantum algorithms to large-scale genomic analysis. The collaboration aims to accelerate the detection of genetic mutations through quantum-enhanced combinatorial optimization, enhancing both the speed and accuracy of genomic data processing beyond classical computing methods. Key applications include precision diagnostics, personalized treatment planning, and genetic risk assessment for diseases such as cancer and neurological disorders.

In August 2025, Quantinuum, a UK-based software company, teamed up with the Wellcome Sanger Institute to advance quantum computing applications in genomics. This partnership is part of the Sanger Institute's Wellcome Leap Quantum for Bio (Q4Bio) challenge, a global initiative aimed at supporting research in quantum-based genomic analysis. The Wellcome Sanger Institute is focused on developing quantum-enhanced predictive genomics solutions.

Major players in the quantum-enhanced predictive genomics market are Google LLC, Microsoft Corporation, Alibaba Group Holding Limited, Amazon Web Services Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Accenture plc, IBM Corporation, Pfizer Inc., Bayer AG, AstraZeneca plc, GlaxoSmithKline plc, Honeywell International Inc., Fujitsu Limited, Eviden, Xanadu Quantum Technologies Inc., Pasqal SA, Rigetti Computing Inc., IonQ Inc., D-Wave Systems Inc.

North America was the largest region in the quantum-enhanced predictive genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quantum-enhanced predictive genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the quantum-enhanced predictive genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quantum-enhanced predictive genomics market consists of revenues earned by entities by providing services such as clinical decision support services, oncology-focused predictive genomics services, and multi-omics integration services. The market value includes the value of related goods sold by the service provider or included within the service offering. The quantum-enhanced predictive genomics market includes sales of quantum-powered epigenetic predictive tools, quantum-integrated personalized preventive health tools, and quantum-enhanced synthetic biology design platforms. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quantum-Enhanced Predictive Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quantum-enhanced predictive genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quantum-enhanced predictive genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quantum-enhanced predictive genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Technology: Quantum Computing; Quantum Machine Learning; Quantum Cryptography; Other Technologies
  • 2) By Deployment Mode: On-Premises; Cloud-Based
  • 3) By Application: Disease Risk Assessment; Drug Discovery; Personalized Medicine; Genomic Data Analysis; Other Applications
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Research Institutes; Healthcare Providers; Other End-Users
  • Subsegments:
  • 1) By Quantum Computing: Gate Based Quantum Computing; Quantum Annealing; Topological Quantum Computing; Photonic Quantum Computing
  • 2) By Quantum Machine Learning: Supervised Learning; Unsupervised Learning; Reinforcement Learning; Deep Learning
  • 3) By Quantum Cryptography: Quantum Key Distribution; Quantum Random Number Generation; Quantum Secure Communication; Post Quantum Cryptography
  • 4) By Other Technologies: Quantum Sensors; Quantum Simulation; Quantum Networking; Hybrid Quantum Classical Systems
  • Companies Mentioned: Google LLC; Microsoft Corporation; Alibaba Group Holding Limited; Amazon Web Services Inc.; Johnson & Johnson Services Inc.; F. Hoffmann-La Roche AG; Accenture plc; IBM Corporation; Pfizer Inc.; Bayer AG; AstraZeneca plc; GlaxoSmithKline plc; Honeywell International Inc.; Fujitsu Limited; Eviden; Xanadu Quantum Technologies Inc.; Pasqal SA; Rigetti Computing Inc.; IonQ Inc.; D-Wave Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Quantum-Enhanced Predictive Genomics Market Characteristics

3. Quantum-Enhanced Predictive Genomics Market Trends And Strategies

4. Quantum-Enhanced Predictive Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Quantum-Enhanced Predictive Genomics Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Quantum-Enhanced Predictive Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Quantum-Enhanced Predictive Genomics Market Growth Rate Analysis
  • 5.4. Global Quantum-Enhanced Predictive Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Quantum-Enhanced Predictive Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Quantum-Enhanced Predictive Genomics Total Addressable Market (TAM)

6. Quantum-Enhanced Predictive Genomics Market Segmentation

  • 6.1. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantum Computing
  • Quantum Machine Learning
  • Quantum Cryptography
  • Other Technologies
  • 6.2. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • On-Premises
  • Cloud-Based
  • 6.3. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disease Risk Assessment
  • Drug Discovery
  • Personalized Medicine
  • Genomic Data Analysis
  • Other Applications
  • 6.4. Global Quantum-Enhanced Predictive Genomics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Research Institutes
  • Healthcare Providers
  • Other End-Users
  • 6.5. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Computing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gate Based Quantum Computing
  • Quantum Annealing
  • Topological Quantum Computing
  • Photonic Quantum Computing
  • 6.6. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Machine Learning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Supervised Learning
  • Unsupervised Learning
  • Reinforcement Learning
  • Deep Learning
  • 6.7. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Quantum Cryptography, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantum Key Distribution
  • Quantum Random Number Generation
  • Quantum Secure Communication
  • Post Quantum Cryptograp
  • 6.8. Global Quantum-Enhanced Predictive Genomics Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Quantum Sensors
  • Quantum Simulation
  • Quantum Networking
  • Hybrid Quantum Classical Systems

7. Quantum-Enhanced Predictive Genomics Market Regional And Country Analysis

  • 7.1. Global Quantum-Enhanced Predictive Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Quantum-Enhanced Predictive Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Quantum-Enhanced Predictive Genomics Market

  • 8.1. Asia-Pacific Quantum-Enhanced Predictive Genomics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Quantum-Enhanced Predictive Genomics Market

  • 9.1. China Quantum-Enhanced Predictive Genomics Market Overview
  • 9.2. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Quantum-Enhanced Predictive Genomics Market

  • 10.1. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Quantum-Enhanced Predictive Genomics Market

  • 11.1. Japan Quantum-Enhanced Predictive Genomics Market Overview
  • 11.2. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Quantum-Enhanced Predictive Genomics Market

  • 12.1. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Quantum-Enhanced Predictive Genomics Market

  • 13.1. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Quantum-Enhanced Predictive Genomics Market

  • 14.1. South Korea Quantum-Enhanced Predictive Genomics Market Overview
  • 14.2. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Quantum-Enhanced Predictive Genomics Market

  • 15.1. Western Europe Quantum-Enhanced Predictive Genomics Market Overview
  • 15.2. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Quantum-Enhanced Predictive Genomics Market

  • 16.1. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Quantum-Enhanced Predictive Genomics Market

  • 17.1. Germany Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Quantum-Enhanced Predictive Genomics Market

  • 18.1. France Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Quantum-Enhanced Predictive Genomics Market

  • 19.1. Italy Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Quantum-Enhanced Predictive Genomics Market

  • 20.1. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Quantum-Enhanced Predictive Genomics Market

  • 21.1. Eastern Europe Quantum-Enhanced Predictive Genomics Market Overview
  • 21.2. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Quantum-Enhanced Predictive Genomics Market

  • 22.1. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Quantum-Enhanced Predictive Genomics Market

  • 23.1. North America Quantum-Enhanced Predictive Genomics Market Overview
  • 23.2. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Quantum-Enhanced Predictive Genomics Market

  • 24.1. USA Quantum-Enhanced Predictive Genomics Market Overview
  • 24.2. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Quantum-Enhanced Predictive Genomics Market

  • 25.1. Canada Quantum-Enhanced Predictive Genomics Market Overview
  • 25.2. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Quantum-Enhanced Predictive Genomics Market

  • 26.1. South America Quantum-Enhanced Predictive Genomics Market Overview
  • 26.2. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Quantum-Enhanced Predictive Genomics Market

  • 27.1. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Quantum-Enhanced Predictive Genomics Market

  • 28.1. Middle East Quantum-Enhanced Predictive Genomics Market Overview
  • 28.2. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Quantum-Enhanced Predictive Genomics Market

  • 29.1. Africa Quantum-Enhanced Predictive Genomics Market Overview
  • 29.2. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Deployment Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Quantum-Enhanced Predictive Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Quantum-Enhanced Predictive Genomics Market Competitive Landscape And Company Profiles

  • 30.1. Quantum-Enhanced Predictive Genomics Market Competitive Landscape
  • 30.2. Quantum-Enhanced Predictive Genomics Market Company Profiles
    • 30.2.1. Google LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Alibaba Group Holding Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Amazon Web Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Quantum-Enhanced Predictive Genomics Market Other Major And Innovative Companies

  • 31.1. F. Hoffmann-La Roche AG
  • 31.2. Accenture plc
  • 31.3. IBM Corporation
  • 31.4. Pfizer Inc.
  • 31.5. Bayer AG
  • 31.6. AstraZeneca plc
  • 31.7. GlaxoSmithKline plc
  • 31.8. Honeywell International Inc.
  • 31.9. Fujitsu Limited
  • 31.10. Eviden
  • 31.11. Xanadu Quantum Technologies Inc.
  • 31.12. Pasqal SA
  • 31.13. Rigetti Computing Inc.
  • 31.14. IonQ Inc.
  • 31.15. D-Wave Systems Inc.

32. Global Quantum-Enhanced Predictive Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quantum-Enhanced Predictive Genomics Market

34. Recent Developments In The Quantum-Enhanced Predictive Genomics Market

35. Quantum-Enhanced Predictive Genomics Market High Potential Countries, Segments and Strategies

  • 35.1 Quantum-Enhanced Predictive Genomics Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Quantum-Enhanced Predictive Genomics Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Quantum-Enhanced Predictive Genomics Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer